Evidence map›Paper›PMID 25588844›Full record

ArticleJournal of cell science2015

Front-signal-dependent accumulation of the RHOA inhibitor FAM65B at leading edges polarizes neutrophils.

Kun Gao, Wenwen Tang, Yuan Li, Pingzhao Zhang, Dejie Wang, Long Yu, Chenji Wang, Dianqing Wu

Open access · greenAbstract read
In one paragraph

Article in Journal of cell science, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
2.4field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. AJournal of medical genetics · 2020
    Article
  9. Article
  10. Article
  11. Revealing a human p53 universe.Nucleic acids research · 2018
    Article
  12. Article
  13. Interaction between Rho GTPases and 14-3-3 Proteins.International journal of molecular sciences · 2017
    Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Effect of shRNA targeted against RhoA on proliferation and migration of human colonic cancer cells.International journal of clinical and experimental pathology · 2015
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Kun GaoState Key Laboratory of Genetic Engineering, Collaborative Innovation Center for Genetics and Development, Institute of Genetics, School of Life Sciences, Fudan University, 220 Handan Road, Shanghai 200433, P.R. China Vascular Biology and Therapeutic Program, Department of Pharmacology, Yale University School of Medicine, 10 Amistad Street, New Haven, CT 06410, USA.
Wenwen TangVascular Biology and Therapeutic Program, Department of Pharmacology, Yale University School of Medicine, 10 Amistad Street, New Haven, CT 06410, USA.
Yuan LiVascular Biology and Therapeutic Program, Department of Pharmacology, Yale University School of Medicine, 10 Amistad Street, New Haven, CT 06410, USA.
Pingzhao ZhangState Key Laboratory of Genetic Engineering, Collaborative Innovation Center for Genetics and Development, Institute of Genetics, School of Life Sciences, Fudan University, 220 Handan Road, Shanghai 200433, P.R. China Institutes of Biomedical Sciences, Fudan University, Shanghai, 200032, P. R. China.
Dejie WangState Key Laboratory of Genetic Engineering, Collaborative Innovation Center for Genetics and Development, Institute of Genetics, School of Life Sciences, Fudan University, 220 Handan Road, Shanghai 200433, P.R. China.
Long YuState Key Laboratory of Genetic Engineering, Collaborative Innovation Center for Genetics and Development, Institute of Genetics, School of Life Sciences, Fudan University, 220 Handan Road, Shanghai 200433, P.R. China Institutes of Biomedical Sciences, Fudan University, Shanghai, 200032, P. R. China.
Chenji WangState Key Laboratory of Genetic Engineering, Collaborative Innovation Center for Genetics and Development, Institute of Genetics, School of Life Sciences, Fudan University, 220 Handan Road, Shanghai 200433, P.R. China chenjiwang@fudan.edu.cn dan.wu@yale.edu.
Dianqing WuVascular Biology and Therapeutic Program, Department of Pharmacology, Yale University School of Medicine, 10 Amistad Street, New Haven, CT 06410, USA chenjiwang@fudan.edu.cn dan.wu@yale.edu.
Fudan University · CNYale University · US

Funding

Signaling Mechanisms for Leukocyte Migration RegulationR01HL108430 · NHLBI · YALE UNIVERSITY · PI WU, DIANQING · 2011 to 2016
$2.4M
Sustained signaling for fibroblast migrationR01HL120465 · NHLBI · YALE UNIVERSITY · PI WU, DIANQING · 2013 to 2016
$1.6M
Identification of novel genes as being important for neutrophil functionsR21AI094525 · NIAID · YALE UNIVERSITY · PI WU, DIANQING · 2012 to 2013
$457k
NHLBI NIH HHS HL108430NHLBI NIH HHS HL120465NHLBI NIH HHS R01 HL108430NHLBI NIH HHS R01 HL120465NIAID NIH HHS R21 AI094525
6 · The paper itself

Abstract

A hallmark of neutrophil polarization is the back localization of active RHOA and phosphorylated myosin light chain (pMLC, also known as MYL2). However, the mechanism for the polarization is not entirely clear. Here, we show that FAM65B, a newly identified RHOA inhibitor, is important for the polarization. When FAM65B is phosphorylated, it binds to 14-3-3 family proteins and becomes more stable. In neutrophils, chemoattractants stimulate FAM65B phosphorylation largely depending on the signals from the front of the cells that include those mediated by phospholipase Cβ (PLCβ) and phosphoinositide 3-kinase γ (PI3Kγ), leading to FAM65B accumulation at the leading edge. Concordantly, FAM65B deficiency in neutrophils resulted in an increase in RHOA activity and localization of pMLC to the front of cells, as well as defects in chemotaxis directionality and adhesion to endothelial cells under flow. These data together elucidate a mechanism for RHOA and pMLC polarization in stimulated neutrophils through direct inhibition of RHOA by FAM65B at the leading edge.

Indexed as

AnimalsCell AdhesionCell Adhesion MoleculesChemotaxisClass Ib Phosphatidylinositol 3-KinaseEndothelial CellsHEK293 CellsHumansMiceMice, KnockoutMyosin Light ChainsNeutrophilsPhospholipase C betaPhosphorylationProteinsrhoA GTP-Binding ProteinCell Adhesion MoleculesClass Ib Phosphatidylinositol 3-KinaseMyosin Light ChainsPhospholipase C betaPik3cg protein, mouseProteinsrhoA GTP-Binding ProteinRHOA protein, humanRhoA protein, mouserho GTP-Binding ProteinsRIPOR2 protein, humanChemotaxisFAM65BNeutrophilPolarizationRHOA

Identifiers

PMID25588844
PMCPMC4342581
OpenAlexW2021749405

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.